Variant growth currently settling at lower 10%-ish levels over baseline. All BA.2.75s seem out of contention except for BN.1 and derivates. Meanwhile it looks a fairly even fight between XBB.1 and BQ.1.1 as expected.
The next months are difficult to predict due to a complex mix of variants, immunity and seasonal effects, but the current fading autumn wave will likely mean a much lower winter wave than expected before.